• Je něco špatně v tomto záznamu ?

The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells

H. Stepankova, M. Swiatkowski, R. Kruszynski, P. Svec, H. Michalkova, V. Smolikova, A. Ridoskova, Z. Splichal, P. Michalek, L. Richtera, P. Kopel, V. Adam, Z. Heger, S. Rex

. 2021 ; 16 (-) : 4431-4449. [pub] 20210701

Jazyk angličtina Země Nový Zéland

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025454

Purpose: The present study deals with the in vitro evaluation of the potential use of coordination compound-based zinc oxide (ZnO) nanoparticles (NPs) for the treatment of triple negative breast cancer cells (TNBrCa). As BrCa is one of the most prevalent cancer types and TNBrCa treatment is difficult due to poor prognosis and a high metastasis rate, finding a more reliable treatment option should be of the utmost interest. Methods: Prepared by reacting zinc carboxylates (formate, acetate, propionate, butyrate, isobutyrate, valerate) and hexamethylenetetramine, 4 distinct coordination compounds were further subjected to two modes of conversion into ZnO NPs - ultrasonication with oleic acid or heating of pure precursors in an air atmosphere. After detailed characterization, the resulting ZnO NPs were subjected to in vitro testing of cytotoxicity toward TNBrCa and normal breast epithelial cells. Further, their biocompatibility was evaluated. Results: The resulting ZnO NPs provide distinct morphological features, size, biocompatibility, and selective cytotoxicity toward TNBrCa cells. They internalize into two types of TNBrCa cells and imbalance their redox homeostasis, influencing their metabolism, morphology, and ultimately leading to their death via apoptosis or necrosis. Conclusion: The crucial properties of ZnO NPs seem to be their morphology, size, and zinc content. The ZnO NPs with the most preferential values of all three properties show great promise for a future potential use in the therapy of TNBrCa.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025454
003      
CZ-PrNML
005      
20211026133805.0
007      
ta
008      
211013s2021 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/IJN.S304902 $2 doi
035    __
$a (PubMed)34234435
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Stepankova, Hana $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia $u Central European Institute of Technology, Brno University of Technology, Brno, Czechia
245    14
$a The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells / $c H. Stepankova, M. Swiatkowski, R. Kruszynski, P. Svec, H. Michalkova, V. Smolikova, A. Ridoskova, Z. Splichal, P. Michalek, L. Richtera, P. Kopel, V. Adam, Z. Heger, S. Rex
520    9_
$a Purpose: The present study deals with the in vitro evaluation of the potential use of coordination compound-based zinc oxide (ZnO) nanoparticles (NPs) for the treatment of triple negative breast cancer cells (TNBrCa). As BrCa is one of the most prevalent cancer types and TNBrCa treatment is difficult due to poor prognosis and a high metastasis rate, finding a more reliable treatment option should be of the utmost interest. Methods: Prepared by reacting zinc carboxylates (formate, acetate, propionate, butyrate, isobutyrate, valerate) and hexamethylenetetramine, 4 distinct coordination compounds were further subjected to two modes of conversion into ZnO NPs - ultrasonication with oleic acid or heating of pure precursors in an air atmosphere. After detailed characterization, the resulting ZnO NPs were subjected to in vitro testing of cytotoxicity toward TNBrCa and normal breast epithelial cells. Further, their biocompatibility was evaluated. Results: The resulting ZnO NPs provide distinct morphological features, size, biocompatibility, and selective cytotoxicity toward TNBrCa cells. They internalize into two types of TNBrCa cells and imbalance their redox homeostasis, influencing their metabolism, morphology, and ultimately leading to their death via apoptosis or necrosis. Conclusion: The crucial properties of ZnO NPs seem to be their morphology, size, and zinc content. The ZnO NPs with the most preferential values of all three properties show great promise for a future potential use in the therapy of TNBrCa.
650    _2
$a antitumorózní látky $x chemie $x farmakologie $7 D000970
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a lidé $7 D006801
650    _2
$a nanočástice $x chemie $7 D053758
650    _2
$a triple-negativní karcinom prsu $x patologie $7 D064726
650    _2
$a oxid zinečnatý $x chemie $x farmakologie $7 D015034
655    _2
$a časopisecké články $7 D016428
700    1_
$a Swiatkowski, Marcin $u Institute of General and Ecological Chemistry, Lodz University of Technology, Lodz, Poland
700    1_
$a Kruszynski, Rafal $u Institute of General and Ecological Chemistry, Lodz University of Technology, Lodz, Poland
700    1_
$a Svec, Pavel $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia
700    1_
$a Michalkova, Hana $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia
700    1_
$a Smolikova, Vendula $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia $u Central European Institute of Technology, Brno University of Technology, Brno, Czechia
700    1_
$a Ridoskova, Andrea $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia $u Central European Institute of Technology, Mendel University in Brno, Brno, Czechia
700    1_
$a Splichal, Zbynek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia $u Central European Institute of Technology, Brno University of Technology, Brno, Czechia
700    1_
$a Michalek, Petr $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia $u Central European Institute of Technology, Brno University of Technology, Brno, Czechia
700    1_
$a Richtera, Lukas $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia $u Central European Institute of Technology, Brno University of Technology, Brno, Czechia
700    1_
$a Kopel, Pavel $u Department of Inorganic Chemistry, Faculty of Science, Palacky University, Olomouc, Czechia
700    1_
$a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia $u Central European Institute of Technology, Brno University of Technology, Brno, Czechia
700    1_
$a Heger, Zbynek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia $u Central European Institute of Technology, Brno University of Technology, Brno, Czechia
700    1_
$a Rex, Simona $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia $u Central European Institute of Technology, Brno University of Technology, Brno, Czechia
773    0_
$w MED00176143 $t International journal of nanomedicine $x 1178-2013 $g Roč. 16, č. - (2021), s. 4431-4449
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34234435 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133811 $b ABA008
999    __
$a ok $b bmc $g 1714486 $s 1145961
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 16 $c - $d 4431-4449 $e 20210701 $i 1178-2013 $m International journal of nanomedicine $n Int J Nanomedicine $x MED00176143
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace